Biotricity, Inc. Common Stock
BTCY
BTCY was delisted on the 2nd of August, 2024.
27 hedge funds and large institutions have $4.79M invested in Biotricity, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 9 closing their positions.
200% more call options, than puts
Call options by funds: $9K | Put options by funds: $3K
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
16% less funds holding
Funds holding: 32 → 27 (-5)
24% less capital invested
Capital invested by funds: $6.27M → $4.79M (-$1.48M)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$103K |
| 2 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
+$87.3K |
| 3 |
PWM
PRW Wealth Management
Quincy,
Massachusetts
|
+$38.9K |
| 4 |
CMA
Cedar Mountain Advisors
Lake Oswego,
Oregon
|
+$21.8K |
| 5 |
SWMP
Signature Wealth Management Partners
Montvale,
New Jersey
|
+$10.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIM
Caldwell Investment Management
Toronto,
Ontario, Canada
|
-$265K |
| 2 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
-$77K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$62.9K |
| 4 |
VF
Virtu Financial
New York
|
-$50K |
| 5 |
BRWM
B. Riley Wealth Management
Memphis,
Tennessee
|
-$28K |
BTCY Hedge Fund Activity: Q2 2022 in Review
27 of the 5,852 institutional investors tracked by Wall St. Rank reported a position in Biotricity, Inc. Common Stock (BTCY) for Q2 2022, worth a combined $4.79M — down 24% from $6.27M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of BTCY and 4 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 6 added.
The largest buyer was BlackRock, adding an estimated $103K. The largest seller was Caldwell Investment Management, exiting entirely with an estimated $265K sold.
- 27 institutional investors held Biotricity, Inc. Common Stock (BTCY) as of Q2 2022, down from 32 in Q1 2022.
- Funds reported $4.79M of Biotricity, Inc. Common Stock stock for Q2 2022, down 24% quarter-over-quarter.
- 4 funds opened new Biotricity, Inc. Common Stock positions in Q2 2022 and 9 closed out, a net change of -5 holders.
- The largest Biotricity, Inc. Common Stock buyer in Q2 2022 was BlackRock, an estimated $103K added.
- The largest Biotricity, Inc. Common Stock seller in Q2 2022 was Caldwell Investment Management, an estimated $265K sold.
Based on aggregated 13F filings for Q2 2022.